Google Übersetzer
Theralink Technologies Inc.
About
0.00USD+0.00 +0.00%
Closed • Updated at 07:05 GMT+00:00Market Cap$6.2K
Volume5.0K
Beta-14.06
RSI43.07
Theralink Technologies Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Sep 27 2018
OncBioMune Initiates Phase 2 Clinical Trial of Novel Vaccine as Front-Line Treatment for Prostate Cancer
Jul 9 2018
OncBioMune’s Phase 2 Clinical Trial of ProscaVax for Early-Stage Prostate Cancer is Now Included on ClinicalTrials.gov
Jul 2 2018
OncBioMune Signs Work Order for Phase 2 Clinical Trial of ProscaVax for Early Stage Prostate Cancer
Jun 20 2018
OncBioMune to Commence Phase 2 Trial of ProscaVax for Early Stage Prostate Cancer Patients
Jun 6 2018
OTC Markets Group Announces Lists of Compliance Downgrades and Caveat Emptor Designations for the Month of May
Recent Videos
Sequire Spotlight Presents Theralink Technologies Inc (THER): Identifying Applicable Pharmaceuticals
Jun 22, 2022
Community Chat
Ask AI
Try asking